XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Cash flows from operating activities:    
Net loss $ (17,031) $ (8,954)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 4,288 4,897
Non-cash inventory credit (1,022) (1,978)
Amortization 301 291
Stock-based compensation 522 747
Deferred income taxes 231 172
Gain sale of equipment (27) (284)
Non-cash restructuring expenses 2,143 330
Foreign currency exchange loss (gain) (97) (347)
Changes in assets and liabilities:    
Accounts receivable (2,029) 1,040
Inventories (2,730)  
Other current assets 737 (1,190)
Other assets 98 (107)
Accounts payable – trade 7,184 963
Deferred revenue (798) 606
Accrued restructuring 753  
Accrued expenses and deferred compensation (335) (1,437)
Income taxes (1,613) (719)
Net cash used in operating activities (9,425) (5,970)
Cash flows from investing activities:    
Capital expenditures (2,440) (3,249)
Proceeds from the sale of equipment 1,450 363
Proceeds from note receivable 270 240
Proceeds from the sale of investments (rabbi trust) 699 1,224
Purchase of investments (rabbi trust) (599) (704)
Net cash used in investing activities (620) (2,126)
Cash flows from financing activities:    
Procceds from line credit 7,898  
Payments on lines of credit (2,500)  
Common stock surrendered for withholding taxes payable (68) (146)
Net cash provided by (used in) financing activities 5,330 (146)
Effect of exchange rate changes on cash and cash equivalents (18) (137)
Decrease in cash and cash equivalents (4,733) (8,379)
Cash and cash equivalents at beginning of period 10,012 20,964
Cash and cash equivalents at end of period $ 5,279 $ 12,585